— Know what they know.
Not Investment Advice

XOMA NASDAQ

XOMA Royalty Corp.
1W: -0.4% 1M: +6.2% 3M: +62.0% YTD: +49.4% 1Y: +57.2% 3Y: +104.0% 5Y: +39.8%
$41.65
-0.17 (-0.41%)
 
Weekly Expected Move ±6.2%
$37 $39 $42 $44 $47
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 64 · $522.3M mcap · 12M float · 1.81% daily turnover · Short 73% of daily vol

Cash Flow Trends

Operating Cash Flow
$3M +120.9% ▲
5Y CAGR: -22.2%
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
$3M +120.9% ▲
5Y CAGR: -20.2%
Dividends Paid
$5M +0.0% ▲
Buybacks
$16M -123307.7% ▼
Net Change in Cash
$27M +151.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$16M-$17M-$41M-$14M$32M
Depreciation & Amort.$7K$104K$934K$216K$3M
Stock-Based Comp.$6M$4M$9M$10M$9M
Change in Working Capital-$886K-$181K-$898K-$3M-$11M
Other Non-Cash Items$2M$694K$13M-$2M-$30M
Operating Cash Flow$23M-$13M-$18M-$14M$3M
— Investing Activities —
Capital Expenditures-$26M-$15M-$17K-$20K$0
Acquisitions (Net)$0$0$0-$1M$4M
Investment Purchases$0$0$0-$3M-$99K
Investment Sales$0$0$0$0$0
Other Investing$0-$5M-$694K-$24M$47M
Investing Cash Flow-$26M-$20M-$711K-$28M$51M
— Financing Activities —
Net Debt Issuance-$4M$0$130M-$7M-$11M
Stock Repurchased$0$0-$148K-$13K-$16M
Dividends Paid-$3M-$5M-$5M-$5M-$5M
Other Financing-$19M$1M-$4M$1M-$3M
Financing Cash Flow$13M-$4M$121M-$11M-$26M
Net Change in Cash$9M-$38M$102M-$53M$27M
Cash End of Period$95M$58M$160M$106M$134M
Free Cash Flow-$4M-$28M-$18M-$14M$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms